A study found that sonodynamic therapy showed no adverse events and demonstrated cancer cell death in 3 patients with ...

Glioblastoma is the most aggressive and most common malignant brain cancer in adults. It is currently treated with surgery, ...

studied 55 cases of recurrent anaplastic astrocytoma and glioblastoma (20 and 35, respectively); in all cases, second surgery was performed; 41 of the 55 patients (75%) underwent postoperative ...

Satoru Osuka, M.D., Ph.D., assistant professor in the University of Alabama at Birmingham Department of Neurosurgery, has been awarded a $50,000 seed grant from the Uncle Kory Foundation to support ...

Reoperation in recurrent glioblastoma patients may improve progression-free and overall survival, especially when tumors are in non-eloquent, accessible brain regions. Factors like age, gender, tumor ...

Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...

A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 ...

A new study from researchers at the University of Manitoba is shedding new light and providing new hope for those living with a rare and fatal brain cancer, the very disease that claimed the life of ...

TPI 287 has been well tolerated in over 350 patients to date, including in clinical trials as a monotherapy and in combination with bevacizumab for the treatment of recurrent glioblastoma ...

On-demand video webcast now available here HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc.